News about COVID

The dominant #SARSCoV2 variant in the US will soon be KP.3. A KP.2 vaccine induced >3-fold neutralizing titers vs KP.3 compared w/ a JN.1 vaccine (mice) 2 companies asserted they would be ready with a KP.2 vaccine But the FDA is going with a JN.1 vaccine www.fda.gov/media/179144/download pic.twitter.com/BsGLhjIbuQ

#SARSCoV2 lineages How #VariantHunters nickname convergent combo mutations? [OG Amino acid single letter code] [Mutation single letter code] (optional spacer(s) -vowel) followed by the codes for the next mutation. For example: Spike F456L & R346T combo: #FLiRT 1/n pic.twitter.com/wEOjpiST1R

#SARSCoV2 #VariantProportions - #USA |06/07/24 @CDCgov #Nowcast 2-Week estimates KP.3 (JN.1.11.1.3) is the top circulating lineage in the USA Signature mutations: Spike F456L & Q493E (#FLuQE) covid.cdc.gov/covid-data-tracker/#variant-proportions 1/n pic.twitter.com/L6hYAVvZ79

Still boggles my mind that minimizers claim that there can't be any lasting adverse impact of COVID on immune systems because of there were, we'd be seeing report after report of unusual infections -- when in fact we *are* seeing report after report of unusual infections.